CA2776534A1 - Piscine reovirus diagnostic compositions - Google Patents

Piscine reovirus diagnostic compositions Download PDF

Info

Publication number
CA2776534A1
CA2776534A1 CA2776534A CA2776534A CA2776534A1 CA 2776534 A1 CA2776534 A1 CA 2776534A1 CA 2776534 A CA2776534 A CA 2776534A CA 2776534 A CA2776534 A CA 2776534A CA 2776534 A1 CA2776534 A1 CA 2776534A1
Authority
CA
Canada
Prior art keywords
seq
nucleic acid
prv
sequence
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2776534A
Other languages
English (en)
French (fr)
Inventor
W. Ian Lipkin
Gustavo Palacios
Ruth Toril Kongtorp
Edgar Brun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Veterinary Institute
Columbia University in the City of New York
Original Assignee
National Veterinary Institute
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43826692&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2776534(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by National Veterinary Institute, Columbia University in the City of New York filed Critical National Veterinary Institute
Publication of CA2776534A1 publication Critical patent/CA2776534A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
CA2776534A 2009-10-02 2010-10-04 Piscine reovirus diagnostic compositions Abandoned CA2776534A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24805809P 2009-10-02 2009-10-02
US61/248,058 2009-10-02
US32504710P 2010-04-16 2010-04-16
US61/325,047 2010-04-16
US38059410P 2010-09-07 2010-09-07
US61/380,594 2010-09-07
PCT/US2010/051348 WO2011041790A1 (en) 2009-10-02 2010-10-04 Piscine reovirus diagnostic compositions

Publications (1)

Publication Number Publication Date
CA2776534A1 true CA2776534A1 (en) 2011-04-07

Family

ID=43826692

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2776534A Abandoned CA2776534A1 (en) 2009-10-02 2010-10-04 Piscine reovirus diagnostic compositions
CA2776386A Active CA2776386C (en) 2009-10-02 2010-10-04 Piscine reovirus immunogenic compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2776386A Active CA2776386C (en) 2009-10-02 2010-10-04 Piscine reovirus immunogenic compositions

Country Status (8)

Country Link
US (3) US9366667B2 (enExample)
EP (2) EP2482825B1 (enExample)
JP (1) JP2013506672A (enExample)
CN (1) CN102647988A (enExample)
CA (2) CA2776534A1 (enExample)
CL (5) CL2012000821A1 (enExample)
DK (1) DK179132B1 (enExample)
WO (2) WO2011041790A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011041790A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
EP3039128B1 (en) * 2013-08-30 2018-12-19 Pharmaq AS Method for propagating a virus
IL230970A0 (en) 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CL2015000980A1 (es) * 2014-04-18 2016-07-01 Upstartdna Co Ltd Standard Entity Métodos para detectar patógenos en peces de agua fría.
WO2015185605A1 (en) * 2014-06-03 2015-12-10 Veterinærinstituttet New reovirus infecting rainbow trout
WO2016075277A1 (en) 2014-11-14 2016-05-19 Patogen Analyse As Novel fish virus and method for detection
IL266234B2 (en) 2014-12-15 2025-10-01 The State Of Israel Mini Of Agriculture & Rural Development Kimron Veterinary Institute A new tilapia virus and its uses
CA3083873A1 (en) 2017-12-06 2019-06-13 Intervet International B.V. Use of a non-structural protein from prv to protect against heart and skeletal muscle inflammation
WO2020069658A1 (zh) * 2018-10-05 2020-04-09 福又达生物科技股份有限公司 鱼病原体检测方法
US10688050B1 (en) 2018-12-21 2020-06-23 Synthon B.V. Pharmaceutical composition comprising ibrutinib
NO344967B1 (en) 2019-01-30 2020-08-03 Patogen As Piscine Orthoreovirus Virulence Markers
CN109971890A (zh) * 2019-04-30 2019-07-05 上海海洋大学 Ii型草鱼呼肠孤病毒的微滴式数字pcr检测试剂盒及其专用引物和探针
CN110079507B (zh) * 2019-05-06 2022-05-20 中国海洋大学 抗牙鲆黏膜免疫球蛋白IgT的单克隆抗体及其应用
CN110408637B (zh) * 2019-08-08 2020-12-25 中国水产科学研究院长江水产研究所 一种草鱼出血病酵母口服疫苗及应用
EP4076515A1 (en) 2019-12-16 2022-10-26 Intervet International B.V. Inactivated piscine orthoreovirus vaccine
NO346211B1 (en) 2020-07-14 2022-04-19 Patogen As Piscine Orthoreovirus Virulence Markers
CN112206317B (zh) * 2020-10-12 2023-09-22 浙江省淡水水产研究所 一种草鱼出血病二价核酸菌蜕疫苗的制备方法
CN112048575A (zh) * 2020-10-26 2020-12-08 深圳市莱孚生物科技有限公司 一种用于鉴定草鱼出血热病毒的引物及探针以及检测方法
CN113527475B (zh) * 2021-06-07 2022-04-29 浙江省农业科学院 一种分泌鸭新型呼肠孤病毒σC蛋白单抗的杂交瘤细胞、单抗及应用
CN114164159B (zh) * 2021-06-21 2023-10-03 湖南师范大学 一种具有防治鱼类杀鲑气和迟缓爱德华氏菌感染的二联疫苗及其制备方法与应用
KR102734012B1 (ko) * 2021-08-19 2024-11-25 성균관대학교산학협력단 바이러스성 출혈성 패혈증 바이러스에 특이적으로 결합하는 항체 또는 이의 항원 결합 단편, 및 이들의 용도
CL2024000227A1 (es) * 2024-01-25 2024-07-12 Univ Santiago Chile Proteína de piscine orthoreovirus; composición de vacuna; y su uso.
CN118853676B (zh) * 2024-09-03 2025-03-07 中国水产科学研究院淡水渔业研究中心 一种草鱼ii型呼肠孤病毒反义rna及其重组载体、试剂盒和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
NZ215865A (en) 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
WO1986006487A1 (en) 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
DK0538496T3 (da) * 1991-08-26 2004-02-23 Baxter Healthcare Sa Rekombinant fjerkrækoppevirus med intakt FPV tk-gen
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
ATE369429T1 (de) 1998-05-08 2007-08-15 Intervet Int Bv Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
US20080256662A1 (en) * 1999-05-10 2008-10-16 Byrum Joseph R Nucleic acid molecules and other molecules associated with plants
CN1170934C (zh) 1999-08-03 2004-10-13 阿克佐诺贝尔公司 源自白斑综合征病毒的蛋白质及其应用
CA2378437C (en) 1999-08-07 2014-01-21 Novartis Ag Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
DK1094069T4 (da) 1999-10-18 2008-07-21 Intervet Int Bv DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
WO2001068865A2 (en) 2000-03-11 2001-09-20 Novartis Ag Fish vaccine against piscirickettsia salmonis
CA2325088A1 (en) 2000-12-01 2002-06-01 Fusogenix Inc. Novel membrane fusion proteins derived from poikilothermic reovirus
CA2456229A1 (en) 2001-08-03 2003-02-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
US7670604B2 (en) * 2002-12-13 2010-03-02 Aurelium Biopharma, Inc. Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
WO2004065415A2 (en) 2003-01-20 2004-08-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. L-amino acid oxidase with cytotoxic activity from aplysia punctata
GB2429711B (en) * 2004-06-11 2008-05-21 Pharmaq As Heart and skeletal muscle inflammation (HSMI) virus
US7361468B2 (en) * 2004-07-02 2008-04-22 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
CN101128768A (zh) 2005-02-22 2008-02-20 日本碍子株式会社 光调制器
US8088976B2 (en) 2005-02-24 2012-01-03 Monsanto Technology Llc Methods for genetic control of plant pest infestation and compositions thereof
WO2007020983A1 (ja) * 2005-08-18 2007-02-22 Japan Science And Technology Agency オオムギｅｓｔ配列を利用して作製された二倍体コムギ遺伝地図を用いるコムギの育種方法
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
MX2009009530A (es) 2007-03-07 2010-05-19 Nventa Biopharmaceuticals Corp Composiciones de acidos nucleicos cerrados bicatenarios.
KR101647843B1 (ko) * 2007-03-12 2016-08-11 온콜리틱스 바이오테크 인코포레이티드 변형된 서열을 갖는 레오바이러스
WO2010024284A1 (ja) * 2008-09-01 2010-03-04 国立大学法人 北海道大学 魚類抗ウイルスワクチン、魚類免疫賦活剤、および魚類免疫付与方法
WO2011041790A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions

Also Published As

Publication number Publication date
EP2482825A4 (en) 2013-06-26
WO2011041790A1 (en) 2011-04-07
WO2011041789A1 (en) 2011-04-07
EP2482825A1 (en) 2012-08-08
CL2016000240A1 (es) 2016-07-29
US9395356B2 (en) 2016-07-19
EP2482824A4 (en) 2013-06-19
US20130072542A1 (en) 2013-03-21
CL2013002907A1 (es) 2014-03-21
CL2012000822A1 (es) 2012-07-20
JP2013506672A (ja) 2013-02-28
DK179132B1 (en) 2017-11-27
CN102647988A (zh) 2012-08-22
US20130058968A1 (en) 2013-03-07
EP2482824B1 (en) 2016-11-30
DK201170227A (en) 2011-05-11
CA2776386C (en) 2018-02-27
US20160287694A1 (en) 2016-10-06
US9366667B2 (en) 2016-06-14
CA2776386A1 (en) 2011-04-07
CL2012000821A1 (es) 2012-08-03
CL2013002933A1 (es) 2014-06-27
EP2482825B1 (en) 2016-11-23
EP2482824A1 (en) 2012-08-08

Similar Documents

Publication Publication Date Title
US9366667B2 (en) Piscine reovirus diagnostic compositions
Wang et al. A new Hendra virus genotype found in Australian flying foxes
Maldonado et al. Evidence of the concurrent circulation of H1N2, H1N1 and H3N2 influenza A viruses in densely populated pig areas in Spain
Boujon et al. Novel encephalomyelitis-associated astrovirus in a muskox (Ovibos moschatus): a surprise from the archives
Wang et al. Laminin receptor is an interacting partner for viral outer capsid protein VP5 in grass carp reovirus infection
WO2011098484A1 (en) Trichodysplasia spinulosa- associated polyomavirus (tsv)
Chia et al. Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
WO2018224516A1 (en) Detection and treatment of pmcv infection in cleaner fish
KR20190123934A (ko) 신규한 중증열성혈소판감소증후군 바이러스
NO20161983A1 (en) New reovirus infecting rainbow trout
CN117866081A (zh) 一种抗新型冠状病毒的全人源单克隆抗体及其用途
Talbi et al. Genetic diversity of perch rhabdoviruses isolates based on the nucleoprotein and glycoprotein genes
Jyothi et al. Epidemiology, molecular prevalence and prevention on canine parvovirus in India: A review
JP2016505267A (ja) アデノウイルスおよびその使用
JP3987430B2 (ja) ノーウォークウイルスに対する抗体及びこの抗体を用いたウイルスの検出方法
Alkan et al. The detection and genetic characterization based on the S1 gene region of BCoVs from respiratory and enteric infections in Turkey
Moncayo et al. West Nile virus and epizootic hemorrhagic disease virus co-infection in a novel host at the Nashville Zoo
US9702016B2 (en) Diagnostic test for virus
Kökkaya et al. Development of an In‐House Antigen ELISA Using Monoclonal and Polyclonal Antibodies Against an Isolated Canine Distemper Virus
Ha et al. Synthetic peptide-derived antibody-based immunohistochemistry for the detection of porcine circovirus 2 in pigs with postweaning multisystemic wasting syndrome
RU2798051C2 (ru) Новый totivirus рыб
Cote et al. Development and characterization of a monoclonal antibody against Taura syndrome virus
Ma et al. Coinfection of SFTSV Genotype A with Rickettsia among Farmers in Northeast
Udahemuka Risk Factors and Molecular Epidemiology of Foot and Mouth Disease Virus and Other Animal Pathogens Infecting African Buffaloes, Cattle and Goats in Eastern Rwanda.
US20150093403A1 (en) Canine circovirus sequences and uses thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151002

FZDE Discontinued

Effective date: 20180928